Robb Knie, CEO and President at Hoth Therapeutics, Inc. (HOTH), bought 25,000 shares at $0.67 ($17K) on 2024-08-16, disclosed to the SEC on 2024-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |